Cisplatin Teva

Medicinal product

(Invented) name

Cisplatin Teva

Active substance (s)

Cisplatina

Strength

0,5 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XA01, Cisplatin

Marketing authorisation holder

Teva Pharma B.V., Nyderlandai

Date of authorisation

2009-04-10

Date of renewal

2010-10-22

Documents

1522_1_3 Pakuotės lapelis 190328.docx

1522_1_3 Cisplatin Teva konc inf RPP 190328.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/1251/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Cisplatina	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
24461	27113	1027113	buteliukas	20 ml N1		Receptinis	LT/1/09/1522/001	Netiekiama	-	-	No	-	-
27249	29806	1029806	buteliukas	50 ml N1		Receptinis	LT/1/09/1522/002	Netiekiama	-	-	No	-	-
27250	29807	1029807	buteliukas	100 ml N1		Receptinis	LT/1/09/1522/003	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-10-28	Išregistruotas
2010-10-22	Perregistruotas
2009-04-10	Registruotas